Modality Fluid Development: Evolving Pipelines and Drug Delivery Solutions

Merck has a long history of being open to utilizing a wide range of delivery technologies for both enabling and life cycle management. In this leadership keynote, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference, Dr Allen Templeton, VP, Pharmaceutical Sciences, discusses how Merck's strategy of utilizing DDS has evolved and the role of enabling drug delivery technologies play in the Merck R&D pipeline. What emerging DDS technologies and modalities does Merck view as the most promising, and why.

To learn more about the upcoming 10th annual PODD: Partnership Opportunities in Drug Delivery conference please visit, www.theconferenceforum.org